nav-left cat-right
cat-right

Seegene Receives FDA Clearance for its Herpes Simp...

Gaithersburg, Maryland and SEOUL, Korea, February 17, 2015 – Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for its TOCE™-based herpes simplex virus (HSV) types 1 and 2 assay. This is the first product that Seegene has taken through the FDA, and it opens the way for Seegene’s other...

Analyzing the Winners and Losers in the Growth of ...

Success of Delivery Device Developers in Solving Formulation Limitations a Key Factor according to Greystone Research Associates (Amherst, NH) – As patients live longer and the prevalence and incidence of chronic ailments increase across the general population, drug developers and their delivery device partners are adapting to address what will become a significant market opportunity. Chronic conditions require drug...

Autoinjectors Gaining Acceptance as Suppliers Adju...

Improved Designs and Enhanced Ease-of-Use Features Key Factors in Patient Acceptance according to Greystone Research Associates (Amherst, NH) – The aging global population is having a major impact on the growing emphasis on drug self-administration. This trend is creating an increased demand for medical devices that are patient-friendly and cost-effective. Autoinjectors, a relatively new class of injection devices, have...

Biomarkers Summit March 18-20,2015 San Diego, CA

The Biomarker Summit 2015, to be held on March 18-20, 2015 in San Diego, CA at the Westin San Diego Hotel, is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization. A wide variety of important topics will be covered including biomarker identification,...

Therapeutic Antibody Drugs Being Designed for Self...

Pipeline Candidates Being Formulated for Subcutaneous Delivery Proliferating according to Greystone Research Associates (Amherst, NH) – The administration of therapeutic antibodies is becoming an increasingly important healthcare treatment option for a growing number diseases and indications having broad implications for patient health and well-being. But to fully exploit the value of this class of therapeutics in both...

Biophysics in Drug Discovery 2015 June 9-12, 2015 ...

The use of biophysical techniques in drug discovery is rapidly increasing, and many pharmaceutical companies have set up in-house biophysical platforms to speed up the target-to-candidate process and improve the quality of small-molecule therapeutics through a better understanding of their interactions with their targets. However, biophysics for drug discovery had not yet been the subject of a dedicated conference: most of...
Page 5 of 147« First...34567...102030...Last »